This is the asx not nasdaq; its cowboy country. Their are biotech guidelines (Code of Best Practice...) not as stringent as sec filings. Aside from the usual ps stuff all asx companies are obliged to ann, of course.
https://www.asx.com.au/documents/research/Code_of_Best_Practice_for_Reporting_by_Life_Science_Companies.pdf
EG: the company has provided info on FPI often, but, as far as I am reasonably aware, have not in this case updated the market on progress of the MAST combo arms progress for imv a long, long time... Is their a delay? Who would know? Should we know?
GLTA.
Ann: First patient dosed in Phase 1 bile tract cancer trial, page-115
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |